Showing results (121-130 of 2,754) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|November 7, 2013
Association of TNF-α polymorphism with prediction of response to TNF blockers in spondyloarthritis and inflammatory bowel disease: a meta-analysisQiang Tong, Liang Zhao, Xiao-Di Qian, et al.
Pharmacogenomics|September 8, 2022
Analysis of the difference in SLCO1B1 and APOE gene polymorphisms between Mongolian and Han populationsRuibing Niu, Liping Guo, Xiaoxian Dong, et al.
Pharmacogenomics|January 19, 2022
Pharmacogenetic differentiation across Latin AmericaGuilherme Suarez-Kurtz, Gilderlanio Santana de Araújo
Pharmacogenomics|February 16, 2019
Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspectiveSophie E Legge, James Tr Walters
Pharmacogenomics|January 15, 2021
Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicityTarek Magdy, Paul W Burridge
Pharmacogenomics|December 15, 2016
Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cellsLiang Yan, Jingyang Liu, Yunlong Zhao, et al.
Pharmacogenomics|March 31, 2017
Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenosonMark Berlacher, Ronald Mastouri, Santosh Philips, et al.
Pharmacogenomics|March 31, 2017
Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectivesMarcelo R Luizon, Ana Ct Palei, Ricardo C Cavalli, et al.
Pharmacogenomics|March 28, 2017
The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studiesMarije J Klumpers, Marieke Jh Coenen, Corrie Em Gidding, et al.
Pharmacogenomics|November 8, 2021
Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomideYasmine S Makarem, Mohammad Salem Hareedy, Manal Hassanien, et al.
Pageof 276